OptimizeRx (OPRX) Competitors

MediaAlpha (NYSE:MAX) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

Do analysts prefer MAX or OPRX?

MediaAlpha currently has a consensus price target of $18.29, indicating a potential upside of 127.92%. OptimizeRx has a consensus price target of $9.06, indicating a potential upside of 18.11%. Given MediaAlpha's stronger consensus rating and higher probable upside, equities research analysts clearly believe MediaAlpha is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediaAlpha	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86
OptimizeRx	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.78

Does the media refer more to MAX or OPRX?

In the previous week, MediaAlpha had 3 more articles in the media than OptimizeRx. MarketBeat recorded 8 mentions for MediaAlpha and 5 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.79 beat MediaAlpha's score of 0.51 indicating that OptimizeRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MediaAlpha	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MAX or OPRX more profitable?

MediaAlpha has a net margin of 1.41% compared to OptimizeRx's net margin of -27.41%. OptimizeRx's return on equity of -4.92% beat MediaAlpha's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MediaAlpha	1.41%	-11.98%	5.19%
OptimizeRx	-27.41%	-4.92%	-3.41%

Which has more volatility and risk, MAX or OPRX?

MediaAlpha has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500.

Does the MarketBeat Community favor MAX or OPRX?

OptimizeRx received 109 more outperform votes than MediaAlpha when rated by MarketBeat users. However, 70.59% of users gave MediaAlpha an outperform vote while only 64.08% of users gave OptimizeRx an outperform vote.

Company	Underperform	Outperform
MediaAlpha	Outperform Votes 48 70.59%	Underperform Votes 20 29.41%
OptimizeRx	Outperform Votes 157 64.08%	Underperform Votes 88 35.92%

Which has preferable earnings & valuation, MAX or OPRX?

OptimizeRx has lower revenue, but higher earnings than MediaAlpha. OptimizeRx is trading at a lower price-to-earnings ratio than MediaAlpha, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediaAlpha	$864.70M	0.62	-$40.42M	$0.30	26.74
OptimizeRx	$92.13M	1.54	-$17.57M	-$1.10	-6.98

Do institutionals and insiders believe in MAX or OPRX?

64.4% of MediaAlpha shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 11.5% of MediaAlpha shares are held by insiders. Comparatively, 6.1% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

MediaAlpha beats OptimizeRx on 11 of the 19 factors compared between the two stocks.